Celestica, Inc. $CLS Shares Sold by Dilation Capital Management LP

Dilation Capital Management LP cut its holdings in shares of Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS) by 41.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 44,095 shares of the technology company’s stock after selling 31,615 shares during the quarter. Celestica comprises 5.4% of Dilation Capital Management LP’s portfolio, making the stock its 8th biggest holding. Dilation Capital Management LP’s holdings in Celestica were worth $10,864,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its holdings in Celestica by 267.9% in the 2nd quarter. Farther Finance Advisors LLC now owns 2,498 shares of the technology company’s stock valued at $390,000 after acquiring an additional 1,819 shares during the period. Park Avenue Securities LLC boosted its position in shares of Celestica by 18.0% in the second quarter. Park Avenue Securities LLC now owns 16,572 shares of the technology company’s stock valued at $2,584,000 after acquiring an additional 2,522 shares during the period. Cigna Investments Inc. New acquired a new position in shares of Celestica in the second quarter valued at about $333,000. Ballentine Partners LLC acquired a new stake in Celestica in the 2nd quarter worth about $328,000. Finally, Wealth Effects LLC bought a new stake in Celestica in the 2nd quarter valued at about $328,000. 67.38% of the stock is owned by institutional investors.

Celestica Trading Down 0.2%

Shares of Celestica stock opened at $310.11 on Thursday. The firm’s 50 day moving average is $309.62 and its 200 day moving average is $259.99. The firm has a market capitalization of $35.67 billion, a PE ratio of 50.34 and a beta of 1.87. Celestica, Inc. has a 1 year low of $58.05 and a 1 year high of $363.40. The company has a current ratio of 1.47, a quick ratio of 0.88 and a debt-to-equity ratio of 0.37.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last announced its quarterly earnings results on Monday, October 27th. The technology company reported $1.58 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $0.13. The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.01 billion. Celestica had a return on equity of 30.53% and a net margin of 6.35%.Celestica’s revenue was up 27.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.04 EPS. Equities research analysts forecast that Celestica, Inc. will post 4.35 earnings per share for the current fiscal year.

Insider Transactions at Celestica

In other Celestica news, Director Laurette T. Koellner acquired 6,000 shares of the company’s stock in a transaction that occurred on Thursday, October 30th. The stock was acquired at an average price of $341.67 per share, for a total transaction of $2,050,020.00. Following the acquisition, the director directly owned 6,000 shares in the company, valued at $2,050,020. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.52% of the stock is currently owned by company insiders.

Celestica News Summary

Here are the key news stories impacting Celestica this week:

Analyst Ratings Changes

Several brokerages recently issued reports on CLS. UBS Group boosted their price target on Celestica from $208.00 to $350.00 and gave the company a “neutral” rating in a research note on Wednesday, October 29th. TD Cowen reissued a “hold” rating and set a $238.00 target price on shares of Celestica in a report on Friday, October 3rd. Zacks Research cut shares of Celestica from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 29th. Royal Bank Of Canada raised their target price on shares of Celestica from $315.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Finally, BNP Paribas Exane reiterated an “outperform” rating and set a $300.00 price target on shares of Celestica in a research report on Thursday, September 25th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $340.75.

View Our Latest Research Report on CLS

About Celestica

(Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

Featured Stories

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.